Delivery Order SPE2DB20D3103-SPE2DB22FP1H7
Award Date
7/7/22
Potential Completion Date
7/8/22
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide MYCOPHENOLIC ACID DR 360 MG TB 120S, a pharmaceutical product. The $1,246.77 firm fixed-price delivery order has a completion date of January 23, 2025 and is not designated as a set-aside contract. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a comprehensive range of...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,364.70 firm fixed-price delivery order is for Mycophenolate 500 mg tablets, a specialty medication. The contract has a ceiling value of $1,364.70 and an ultimate completion date of February 12, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that...
This federal contract award, valued at $4,788.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYCOPHENOLATE 500 MG TABLET 100S, a medical product, and has an ultimate completion date of April 8, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,379.40, is for the delivery of 4,564,886 units of the pharmaceutical drug Mycophenolate 500 mg tablets. The contract has a completion date of June 13, 2024 and is a firm fixed-price contract. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,544.52, is a Firm Fixed Price Delivery Order for the supply of Mycophenolate 500 mg tablets. The contract has an ultimate completion date of March 25, 2025 and was awarded on March 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, a firm fixed price delivery order, is for the supply of Mycophenolate 500 mg tablets. The contract has a ceiling value of $2,073.55 and a period of performance through April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,686.21, is for the delivery of MYCOPHENOLATE 200 MG/ML SUSP 160ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $47,207.10, was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp Corporate Office Division. The award is for the delivery of mycophenolate 200 mg/ml suspension, a pharmaceutical product used in medical treatments. This contract is a delivery order (CLIN) that is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,266.19, is for the delivery of MYCOPHENOLATE 500 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of April 3, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $1,028.61, is for the delivery of 4559144199 - Mycophenolate 500 mg vials. The contract has an ultimate completion date of November 21, 2022 and was awarded on November 18, 2022 as a Firm Fixed Price Delivery Order. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier...